{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T13:30:11Z","timestamp":1770557411472,"version":"3.49.0"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-025-03467-9","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T05:40:04Z","timestamp":1741930804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the ocular involvement in multiple myeloma: a comprehensive review of 70-year clinical studies"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7968-1336","authenticated-orcid":false,"given":"Matteo","family":"Ripa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Schipa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Aceto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeraj Apoorva","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"key":"3467_CR1","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.3390\/CURRONCOL30050334","volume":"30","author":"BE Monteith","year":"2023","unstructured":"Monteith BE, Sandhu I, Lee AS (2023) Management of multiple myeloma: a review for general practitioners in oncology. Curr Oncol 30:4382. https:\/\/doi.org\/10.3390\/CURRONCOL30050334","journal-title":"Curr Oncol"},{"key":"3467_CR2","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.3324\/haematol.2023.282905","volume":"108","author":"A McCurdy","year":"2023","unstructured":"McCurdy A, Seow H, Pond GP et al (2023) Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study. Haematologica 108:3384\u20133391. https:\/\/doi.org\/10.3324\/haematol.2023.282905","journal-title":"Haematologica"},{"key":"3467_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2023.103920","volume":"31","author":"MS Abduh","year":"2024","unstructured":"Abduh MS (2024) An overview of multiple myeloma: a monoclonal plasma cell malignancy\u2019s diagnosis, management, and treatment modalities. Saudi J Biol Sci 31:103920. https:\/\/doi.org\/10.1016\/j.sjbs.2023.103920","journal-title":"Saudi J Biol Sci"},{"key":"3467_CR4","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1038\/leu.2014.98","volume":"28","author":"WI Gonsalves","year":"2014","unstructured":"Gonsalves WI, Rajkumar SV, Gupta V et al (2014) Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma. Leukemia 28:2060\u20132065. https:\/\/doi.org\/10.1038\/leu.2014.98","journal-title":"Leukemia"},{"key":"3467_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41571-018-0018-y","volume":"15","author":"SK Kumar","year":"2018","unstructured":"Kumar SK, Rajkumar SV (2018) The multiple myelomas - current concepts in cytogenetic classification and therapy. Nat Rev Clin Oncol 15:409\u2013421. https:\/\/doi.org\/10.1038\/s41571-018-0018-y","journal-title":"Nat Rev Clin Oncol"},{"key":"3467_CR6","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A et al (2014) International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15:e538\u2013e548. https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5","journal-title":"Lancet Oncol"},{"key":"3467_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41408-022-00719-0","volume":"12","author":"SV Rajkumar","year":"2022","unstructured":"Rajkumar SV, Kumar S, Lonial S (2022) Mateos MV (2022) Smoldering multiple myeloma current treatment algorithms. Blood Cancer J 12:129. https:\/\/doi.org\/10.1038\/s41408-022-00719-0","journal-title":"Blood Cancer J"},{"key":"3467_CR8","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1182\/BLOOD-2014-09-568899","volume":"125","author":"SV Rajkumar","year":"2015","unstructured":"Rajkumar SV, Landgren O, Mateos MV (2015) Smoldering multiple myeloma. Blood 125:3069\u20133075. https:\/\/doi.org\/10.1182\/BLOOD-2014-09-568899","journal-title":"Blood"},{"key":"3467_CR9","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1016\/j.clml.2015.08.010","volume":"15","author":"SV Rajkumar","year":"2015","unstructured":"Rajkumar SV (2015) New diagnostic criteria for multiple myeloma. Clin Lymphoma Myeloma Leuk 15:e4\u2013e5. https:\/\/doi.org\/10.1016\/j.clml.2015.08.010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"3467_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/BJO.39.4.233","volume":"39","author":"E Clarke","year":"1955","unstructured":"Clarke E (1955) Ophthalmological complications of multiple myelomatosis. Br J Ophthalmol 39:233\u2013236. https:\/\/doi.org\/10.1136\/BJO.39.4.233","journal-title":"Br J Ophthalmol"},{"key":"3467_CR11","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1001\/archopht.1961.00960010304003","volume":"66","author":"RA Allen","year":"1961","unstructured":"Allen RA, Miller DH, Straatsma BR (1961) Cysts of the posterior ciliary body (pars plana). Arch Ophthalmol 66:302\u2013313. https:\/\/doi.org\/10.1001\/archopht.1961.00960010304003","journal-title":"Arch Ophthalmol"},{"key":"3467_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1001\/archopht.1965.00970030489008","volume":"73","author":"N Ashton","year":"1965","unstructured":"Ashton N (1965) Ocular changes in multiple myelomatosis. Arch Ophthalmol 73:487\u2013494. https:\/\/doi.org\/10.1001\/archopht.1965.00970030489008","journal-title":"Arch Ophthalmol"},{"key":"3467_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12929-019-0558-1","volume":"26","author":"DY Tsai","year":"2019","unstructured":"Tsai DY, Hung KH, Chang CW, Lin KI (2019) Regulatory mechanisms of B cell responses and the implication in B cell-related diseases. J Biomed Sci 26:1\u201313. https:\/\/doi.org\/10.1186\/S12929-019-0558-1","journal-title":"J Biomed Sci"},{"key":"3467_CR14","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1182\/blood.V97.3.729","volume":"97","author":"M Chesi","year":"2001","unstructured":"Chesi M, Brents LA, Ely SA et al (2001) Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma. Blood 97:729\u2013736. https:\/\/doi.org\/10.1182\/blood.V97.3.729","journal-title":"Blood"},{"key":"3467_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/978-3-642-60801-8_30","volume":"224","author":"PL Bergsagel","year":"1997","unstructured":"Bergsagel PL, Nardini E, Brents L et al (1997) IgH translocations in multiple myeloma: a nearly universal event that rarely involves c-myc. Curr Top Microbiol Immunol 224:283\u2013287. https:\/\/doi.org\/10.1007\/978-3-642-60801-8_30","journal-title":"Curr Top Microbiol Immunol"},{"key":"3467_CR16","doi-asserted-by":"publisher","first-page":"153303382110652","DOI":"10.1177\/15330338211065252","volume":"21","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Zhang C, Lu L et al (2022) The prognostic role of cyclin D1 in multiple myeloma: a systematic review and meta-analysis. Technol Cancer Res Treat 21:15330338211065252. https:\/\/doi.org\/10.1177\/15330338211065252","journal-title":"Technol Cancer Res Treat"},{"key":"3467_CR17","doi-asserted-by":"publisher","first-page":"11075","DOI":"10.3390\/IJMS231911075","volume":"23","author":"A Azagra","year":"2022","unstructured":"Azagra A, Cobaleda C (2022) NSD2 as a promising target in hematological disorders. Int J Mol Sci 23:11075. https:\/\/doi.org\/10.3390\/IJMS231911075","journal-title":"Int J Mol Sci"},{"key":"3467_CR18","doi-asserted-by":"publisher","first-page":"68350","DOI":"10.18632\/oncotarget.12029","volume":"7","author":"SJ Kim","year":"2016","unstructured":"Kim SJ, Shin HT, Lee HO, Kim NK, Yun JW, Hwang JH, Kim K, Park WY (2016) Recurrent mutations of MAPK pathway genes in multiple myeloma but not in amyloid light-chain amyloidosis. Oncotarget 7:68350\u201368359. https:\/\/doi.org\/10.18632\/oncotarget.12029","journal-title":"Oncotarget"},{"key":"3467_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/BIOMEDICINES6020059","volume":"6","author":"P Roy","year":"2018","unstructured":"Roy P, Sarkar UA, Basak S (2018) The NF-\u03baB activating pathways in multiple myeloma. Biomedicines 6:59. https:\/\/doi.org\/10.3390\/BIOMEDICINES6020059","journal-title":"Biomedicines"},{"key":"3467_CR20","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.3390\/cancers11111738","volume":"11","author":"H Handa","year":"2019","unstructured":"Handa H, Murakami Y, Ishihara R et al (2019) The role and function of microrna in the pathogenesis of multiple myeloma. Cancers (Basel) 11:1738. https:\/\/doi.org\/10.3390\/cancers11111738","journal-title":"Cancers (Basel)"},{"key":"3467_CR21","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s41417-020-00291-4","volume":"28","author":"D Chen","year":"2021","unstructured":"Chen D, Yang X, Liu M, Zhang Z, Xing E (2021) Roles of miRNA dysregulation in the pathogenesis of multiple myeloma. Cancer Gene Ther 28:1256\u20131268. https:\/\/doi.org\/10.1038\/s41417-020-00291-4","journal-title":"Cancer Gene Ther"},{"key":"3467_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/leu.2008.336","volume":"23","author":"GD Roodman","year":"2009","unstructured":"Roodman GD (2009) Pathogenesis of myeloma bone disease. Leukemia 23:435\u2013441. https:\/\/doi.org\/10.1038\/leu.2008.336","journal-title":"Leukemia"},{"key":"3467_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1182\/blood-2012-01-379024","volume":"120","author":"IM Ghobrial","year":"2012","unstructured":"Ghobrial IM (2012) Myeloma as a model for the process of metastasis: implications for therapy. Blood 120:20\u201330. https:\/\/doi.org\/10.1182\/blood-2012-01-379024","journal-title":"Blood"},{"key":"3467_CR24","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1172\/JCI66517","volume":"123","author":"AM Roccaro","year":"2013","unstructured":"Roccaro AM, Sacco A, Maiso P et al (2013) BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J Clin Invest 123:1542\u20131555. https:\/\/doi.org\/10.1172\/JCI66517","journal-title":"J Clin Invest"},{"key":"3467_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/medsci9010003","volume":"9","author":"SA Padala","year":"2021","unstructured":"Padala SA, Barsouk A, Barsouk A et al (2021) Epidemiology, staging, and management of multiple myeloma. Med Sci 9:3. https:\/\/doi.org\/10.3390\/medsci9010003","journal-title":"Med Sci"},{"key":"3467_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4314\/WAJM.V26I4.28324","volume":"26","author":"AE Omoti","year":"2007","unstructured":"Omoti AE, Omoti CE (2007) Ophthalmic manifestations of multiple myeloma. West Afr J Med 26:265\u2013268. https:\/\/doi.org\/10.4314\/WAJM.V26I4.28324","journal-title":"West Afr J Med"},{"key":"3467_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3109\/14639237909017762","volume":"4","author":"HB Skinner","year":"1979","unstructured":"Skinner HB (1979) Velocity-diameter relationships of the microcirculation. Med Inform (Lond) 4:243\u2013256. https:\/\/doi.org\/10.3109\/14639237909017762","journal-title":"Med Inform (Lond)"},{"key":"3467_CR28","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1182\/BLOOD-2018-06-846816","volume":"132","author":"MA Gertz","year":"2018","unstructured":"Gertz MA (2018) Acute hyperviscosity: syndromes and management. Blood 132:1379. https:\/\/doi.org\/10.1182\/BLOOD-2018-06-846816","journal-title":"Blood"},{"key":"3467_CR29","doi-asserted-by":"publisher","first-page":"H1770","DOI":"10.1152\/AJPHEART.1992.263.6.H1770","volume":"263","author":"AR Pries","year":"1992","unstructured":"Pries AR, Neuhaus D, Gaehtgens P (1992) Blood viscosity in tube flow: dependence on diameter and hematocrit. Am J Physiol 263:H1770\u2013H1778. https:\/\/doi.org\/10.1152\/AJPHEART.1992.263.6.H1770","journal-title":"Am J Physiol"},{"key":"3467_CR30","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1053\/META.2000.6264","volume":"49","author":"C Otto","year":"2000","unstructured":"Otto C, Richter WO, Schwandt P (2000) Contribution of fibrinogen and lipoproteins to plasma viscosity in hypercholesterolemia and hypertriglyceridemia: evaluation by selective depletion of low-density lipoproteins or fibrinogen. Metabolism 49:810\u2013813. https:\/\/doi.org\/10.1053\/META.2000.6264","journal-title":"Metabolism"},{"key":"3467_CR31","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1055\/s-2003-44554","volume":"29","author":"J Mehta","year":"2003","unstructured":"Mehta J, Singhal S (2003) Hyperviscosity syndrome in plasma cell dyscrasias. Semin Thromb Hemost 29:467\u2013471. https:\/\/doi.org\/10.1055\/s-2003-44554","journal-title":"Semin Thromb Hemost"},{"key":"3467_CR32","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2141.1975.tb01862.x","volume":"30","author":"G Virella","year":"1975","unstructured":"Virella G, Preto RV, Gra\u00e7a F (1975) Polymerized monoclonal IgA in two patients with myelomatosis and hyperviscosity syndrome. Br J Haematol 30:479\u2013487. https:\/\/doi.org\/10.1111\/j.1365-2141.1975.tb01862.x","journal-title":"Br J Haematol"},{"key":"3467_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22041766","volume":"22","author":"Y Kawata","year":"2021","unstructured":"Kawata Y, Hirano H, Takahashi R et al (2021) Detailed structure and pathophysiological roles of the IgA-albumin complex in multiple myeloma. Int J Mol Sci 22:1\u201311. https:\/\/doi.org\/10.3390\/ijms22041766","journal-title":"Int J Mol Sci"},{"key":"3467_CR34","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/J.AMJMED.2018.02.022","volume":"131","author":"RM Geha","year":"2018","unstructured":"Geha RM, Tierney LM (2018) Blood is thicker: hyperviscosity syndrome. Am J Med 131:916\u2013917. https:\/\/doi.org\/10.1016\/J.AMJMED.2018.02.022","journal-title":"Am J Med"},{"key":"3467_CR35","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3109\/01676830.2011.648808","volume":"31","author":"NWR Slingerland","year":"2012","unstructured":"Slingerland NWR, Sonneveld P, Hollander JCD, Bleyen I (2012) Marked bilateral lower eyelid ectropion in cutis laxa: a paraneoplastic process in multiple myeloma. Orbit 31:174\u2013176. https:\/\/doi.org\/10.3109\/01676830.2011.648808","journal-title":"Orbit"},{"key":"3467_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.21037\/AOB.2017.07.01","volume":"2","author":"RK Nambiar","year":"2017","unstructured":"Nambiar RK, Nair SG, Mathew SP, Manohar AT (2017) Ptosis and diplopia\u2014sole manifestations in multiple myeloma. Ann Blood 2:9\u20139. https:\/\/doi.org\/10.21037\/AOB.2017.07.01","journal-title":"Ann Blood"},{"key":"3467_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/13506129.2013.839807","volume":"30","author":"M Galea","year":"2015","unstructured":"Galea M, Mcmillan N, Weir C (2015) Diplopia and variable ptosis as the sole initial findings in a case of orbital plasmacytoma and multiple myeloma. Semin Ophthalmol 30:235\u2013237. https:\/\/doi.org\/10.3109\/13506129.2013.839807","journal-title":"Semin Ophthalmol"},{"key":"3467_CR38","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/01.ICO.0000154381.13237.A3","volume":"24","author":"DA Goldstein","year":"2005","unstructured":"Goldstein DA, Schteingart MT, Birnbaum AD, Tessler HH (2005) Bilateral eyelid ecchymoses and corneal crystals: an unusual presentation of multiple myeloma. Cornea 24:757\u2013758. https:\/\/doi.org\/10.1097\/01.ICO.0000154381.13237.A3","journal-title":"Cornea"},{"key":"3467_CR39","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/J.JBSPIN.2005.03.008","volume":"73","author":"S Langlois","year":"2006","unstructured":"Langlois S, Brochot P, Reguiai Z et al (2006) Necrobiotic xanthogranuloma with multiple myeloma. Case report and pathogenic hypotheses. Joint Bone Spine 73:120\u2013122. https:\/\/doi.org\/10.1016\/J.JBSPIN.2005.03.008","journal-title":"Joint Bone Spine"},{"key":"3467_CR40","doi-asserted-by":"publisher","first-page":"117822421986823","DOI":"10.1177\/1178224219868235","volume":"13","author":"SA Bird","year":"2019","unstructured":"Bird SA, Boyd K (2019) Multiple myeloma: an overview of management. Palliat Care Soc Pract 13:1178224219868235. https:\/\/doi.org\/10.1177\/1178224219868235","journal-title":"Palliat Care Soc Pract"},{"key":"3467_CR41","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0025-6196(11)64890-8","volume":"73","author":"YK Keung","year":"1998","unstructured":"Keung YK, Yung C, Wong JW et al (1998) Association of temporal arteritis, retinal vasculitis, and xanthomatosis with multiple myeloma: case report and literature review. Mayo Clin Proc 73:657\u2013660. https:\/\/doi.org\/10.1016\/S0025-6196(11)64890-8","journal-title":"Mayo Clin Proc"},{"key":"3467_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/01676830601169122","volume":"26","author":"MN Lazaridou","year":"2007","unstructured":"Lazaridou MN, Micallef-Eynaud P, Hanna IT (2007) Soft tissue plasmacytoma of the orbit as part of the spectrum of multiple myeloma. Orbit 26:315\u2013318. https:\/\/doi.org\/10.1080\/01676830601169122","journal-title":"Orbit"},{"key":"3467_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.35119\/ASJOO.V13I1.15","volume":"13","author":"RA Razak","year":"2011","unstructured":"Razak RA, Thamboo TP, Amrith S (2011) Extramedullary plasmacytoma of the orbit as initial presentation of multiple myeloma. Asian J Ophthalmol 13:24\u201326. https:\/\/doi.org\/10.35119\/ASJOO.V13I1.15","journal-title":"Asian J Ophthalmol"},{"key":"3467_CR44","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4274\/TJO.73645","volume":"46","author":"M Vatansever","year":"2016","unstructured":"Vatansever M, Bozkurt FM, Din\u00e7 E et al (2016) Orbital metastasis of multiple myeloma: case report. Turk J Ophthalmol 46:148. https:\/\/doi.org\/10.4274\/TJO.73645","journal-title":"Turk J Ophthalmol"},{"key":"3467_CR45","doi-asserted-by":"publisher","first-page":"001149","DOI":"10.12890\/2020_001149","volume":"7","author":"A Matos","year":"2020","unstructured":"Matos A, Goulart A, Ribeiro A, Freitas R, Monteiro C, Martins P (2020) Orbital plasmacytoma, an uncommon presentation of advanced multiple myeloma. Eur J Case Rep Intern Med 7:001149. https:\/\/doi.org\/10.12890\/2020_001149","journal-title":"Eur J Case Rep Intern Med"},{"key":"3467_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/252310","volume":"2012","author":"M Hassan","year":"2012","unstructured":"Hassan M, Alirhayim Z, Sroujieh L, Hassan S (2012) Multiple myeloma of the orbit. Case Rep Ophthalmol Med 2012:1\u20132. https:\/\/doi.org\/10.1155\/2012\/252310","journal-title":"Case Rep Ophthalmol Med"},{"key":"3467_CR47","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4274\/TJH.2017.0283","volume":"35","author":"S Demircio\u011flu","year":"2018","unstructured":"Demircio\u011flu S, Aydo\u011fdu D, \u00c7eneli \u00d6 (2018) Expansion of a myeloma-associated lesion from orbita to the cerebrum. Turk J Haematol 35:92\u201393. https:\/\/doi.org\/10.4274\/TJH.2017.0283","journal-title":"Turk J Haematol"},{"key":"3467_CR48","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1590\/S0004-27492009000200020","volume":"72","author":"IL Romero","year":"2009","unstructured":"Romero IL, de Campos FAG, Damasceno RWF et al (2009) Plasmacytoma of the orbit involving lacrimal gland with secondary transformation into multiple myeloma: case report. Arq Bras Oftalmol 72:236\u2013238. https:\/\/doi.org\/10.1590\/S0004-27492009000200020","journal-title":"Arq Bras Oftalmol"},{"key":"3467_CR49","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1017\/S031716710004662X","volume":"12","author":"JY Chu","year":"1985","unstructured":"Chu JY, Lewis AJ, Cowan DH (1985) IgDK multiple myeloma presenting as unilateral proptosis. Can J Neurol Sci 12:69\u201372. https:\/\/doi.org\/10.1017\/S031716710004662X","journal-title":"Can J Neurol Sci"},{"key":"3467_CR50","doi-asserted-by":"publisher","first-page":"NP1","DOI":"10.1177\/1120672120929959","volume":"31","author":"M Mani","year":"2021","unstructured":"Mani M, Kasturi N, Sravya R et al (2021) Orbital plasmacytoma as the presenting feature in multiple myeloma. Eur J Ophthalmol 31:NP1\u2013NP4. https:\/\/doi.org\/10.1177\/1120672120929959","journal-title":"Eur J Ophthalmol"},{"key":"3467_CR51","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/J.1365-2257.1986.TB00090.X","volume":"8","author":"C Carter","year":"1986","unstructured":"Carter C, Greaves M, Preston FE (1986) Orbital plasmacytoma in established myeloma\u2013a report of two cases. Clin Lab Haematol 8:155\u2013159. https:\/\/doi.org\/10.1111\/J.1365-2257.1986.TB00090.X","journal-title":"Clin Lab Haematol"},{"key":"3467_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/HMED.2022.0383","volume":"29","author":"OF S\u0131m\u0131tc\u0131oglu","year":"2023","unstructured":"S\u0131m\u0131tc\u0131oglu OF, B\u0131y\u0131kl\u0131 E, Alahdab Y, Ad\u0131n H (2023) Orbital and dural involvement in multiple myeloma. Br J Hosp Med (Lond) 29:1. https:\/\/doi.org\/10.12968\/HMED.2022.0383","journal-title":"Br J Hosp Med (Lond)"},{"key":"3467_CR53","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000527273","volume":"8","author":"N Permaisuari","year":"2023","unstructured":"Permaisuari N, Anggraini N, Mahyuddin M et al (2023) A case series of aggressive orbital plasmacytomas. Ocul Oncol Pathol 8:197\u2013202. https:\/\/doi.org\/10.1159\/000527273","journal-title":"Ocul Oncol Pathol"},{"key":"3467_CR54","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/J.SURVOPHTHAL.2009.04.012","volume":"54","author":"CN Burkat","year":"2009","unstructured":"Burkat CN, Van Buren JJ, Lucarelli MJ (2009) Characteristics of orbital multiple myeloma: a case report and literature review. Surv Ophthalmol 54:697\u2013704. https:\/\/doi.org\/10.1016\/J.SURVOPHTHAL.2009.04.012","journal-title":"Surv Ophthalmol"},{"key":"3467_CR55","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.3324\/HAEMATOL.2012.065698","volume":"97","author":"SZ Usmani","year":"2012","unstructured":"Usmani SZ, Heuck C, Mitchell A et al (2012) Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents. Haematologica 97:1761\u20131767. https:\/\/doi.org\/10.3324\/HAEMATOL.2012.065698","journal-title":"Haematologica"},{"key":"3467_CR56","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/annonc\/mdp329","volume":"21","author":"M Varettoni","year":"2010","unstructured":"Varettoni M, Corso A, Pica G et al (2010) Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients. Ann Oncol 21:325\u2013330. https:\/\/doi.org\/10.1093\/annonc\/mdp329","journal-title":"Ann Oncol"},{"key":"3467_CR57","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1742-6413-3-19","volume":"3","author":"A Sharma","year":"2006","unstructured":"Sharma A, Kaushal M, Chaturvedi NK, Yadav R (2006) Cytodiagnosis of multiple myeloma presenting as orbital involvement: a case report. Cytojournal 3:19. https:\/\/doi.org\/10.1186\/1742-6413-3-19","journal-title":"Cytojournal"},{"key":"3467_CR58","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1182\/BLOOD-2006-07-035857","volume":"109","author":"Y Alsayed","year":"2007","unstructured":"Alsayed Y, Ngo H, Runnels J et al (2007) Mechanisms of regulation of CXCR4\/SDF-1 (CXCL12)\u2013dependent migration and homing in multiple myeloma. Blood 109:2708\u20132717. https:\/\/doi.org\/10.1182\/BLOOD-2006-07-035857","journal-title":"Blood"},{"key":"3467_CR59","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/BJH.13383","volume":"169","author":"M Weinstock","year":"2015","unstructured":"Weinstock M, Aljawai Y, Morgan EA et al (2015) Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation. Br J Haematol 169:851\u2013858. https:\/\/doi.org\/10.1111\/BJH.13383","journal-title":"Br J Haematol"},{"key":"3467_CR60","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1200\/JCO.2011.34.9290","volume":"29","author":"J Blad\u00e9","year":"2011","unstructured":"Blad\u00e9 J, Fern\u00e1ndez De Larrea C, Rosi\u00f1ol L et al (2011) Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach. J Clin Oncol 29:3805\u20133812. https:\/\/doi.org\/10.1200\/JCO.2011.34.9290","journal-title":"J Clin Oncol"},{"key":"3467_CR61","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0002-9394(78)90230-1","volume":"86","author":"GK Klintworth","year":"1978","unstructured":"Klintworth GK, Bredehoeft SJ, Reed JW (1978) Analysis of corneal crystalline deposits in multiple myeloma. Am J Ophthalmol 86:303\u2013313. https:\/\/doi.org\/10.1016\/0002-9394(78)90230-1","journal-title":"Am J Ophthalmol"},{"key":"3467_CR62","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/00003226-199709000-00019","volume":"16","author":"EM Chong","year":"1997","unstructured":"Chong EM, Campbell RJ, Bourne WM (1997) Vortex keratopathy in a patient with multiple myeloma. Cornea 16:592\u2013594","journal-title":"Cornea"},{"key":"3467_CR63","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/00003226-199211000-00017","volume":"11","author":"JD Auran","year":"1992","unstructured":"Auran JD, Donn A, Hyman GA (1992) Multiple myeloma presenting as vortex crystalline keratopathy and complicated by endocapsular hematoma. Cornea 11:584\u2013585. https:\/\/doi.org\/10.1097\/00003226-199211000-00017","journal-title":"Cornea"},{"key":"3467_CR64","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.ajo.2005.11.059","volume":"141","author":"YC Shen","year":"2006","unstructured":"Shen YC, Wang CY, Huang TY et al (2006) Multiple myeloma manifesting as a salmon patch conjunctival mass. Am J Ophthalmol 141:948\u2013949. https:\/\/doi.org\/10.1016\/j.ajo.2005.11.059","journal-title":"Am J Ophthalmol"},{"key":"3467_CR65","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/01676830.2019.1691608","volume":"39","author":"E Ben Artsi","year":"2020","unstructured":"Ben Artsi E, Barkley MR, Khong JJ et al (2020) Multiple myeloma manifesting as an ocular salmon patch - a case report. Orbit 39:379\u2013382. https:\/\/doi.org\/10.1080\/01676830.2019.1691608","journal-title":"Orbit"},{"key":"3467_CR66","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/ICO.0000000000001071","volume":"36","author":"A Bradley","year":"2017","unstructured":"Bradley A, Estes A, Ulrich L et al (2017) Epibulbar Plasmacytoma Masquerading as Subconjunctival Hemorrhage in a Patient With Multiple Myeloma. Cornea 36:249\u2013251. https:\/\/doi.org\/10.1097\/ICO.0000000000001071","journal-title":"Cornea"},{"key":"3467_CR67","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/2474126419893175","volume":"4","author":"S Mohamed","year":"2020","unstructured":"Mohamed S, Silvasi T, Kubat A, Aaberg T (2020) Unilateral multiple extramedullary plasmacytoma of the choroid and conjunctiva: a case report. J Vitreoretin Dis 4:152. https:\/\/doi.org\/10.1177\/2474126419893175","journal-title":"J Vitreoretin Dis"},{"key":"3467_CR68","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4103\/0974-620X.99384","volume":"5","author":"AF Felipe","year":"2012","unstructured":"Felipe AF, Nottage JM, Rapuano CJ (2012) Recurrent bilateral subconjunctival hemorrhage as an initial presentation of multiple myeloma. Oman J Ophthalmol 5:133\u2013134. https:\/\/doi.org\/10.4103\/0974-620X.99384","journal-title":"Oman J Ophthalmol"},{"key":"3467_CR69","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1016\/J.CLML.2013.09.012","volume":"14","author":"TP Wang","year":"2014","unstructured":"Wang TP, Safran SG, Richter JR et al (2014) Subepithelial corneal immunoglobulin deposition as a manifestation of multiple myeloma: a case report and literature review. Clin Lymphoma Myeloma Leuk 14:e39-42. https:\/\/doi.org\/10.1016\/J.CLML.2013.09.012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"3467_CR70","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/ICO.0B013E31815B82CD","volume":"27","author":"M Nakatsukasa","year":"2008","unstructured":"Nakatsukasa M, Sotozono C, Tanioka H et al (2008) Diagnosis of multiple myeloma in a patient with atypical corneal findings. Cornea 27:249\u2013251. https:\/\/doi.org\/10.1097\/ICO.0B013E31815B82CD","journal-title":"Cornea"},{"key":"3467_CR71","doi-asserted-by":"publisher","DOI":"10.1001\/JAMAOPHTHALMOL.2018.1505","volume":"136","author":"AMJ Turnbull","year":"2018","unstructured":"Turnbull AMJ, Karmiris E, Anderson DF (2018) Active IgG\u03ba multiple myeloma presenting with crystalline keratopathy. JAMA Ophthalmol 136:e181505. https:\/\/doi.org\/10.1001\/JAMAOPHTHALMOL.2018.1505","journal-title":"JAMA Ophthalmol"},{"key":"3467_CR72","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/01.ICO.0000231492.89539.EB","volume":"26","author":"C Parghi","year":"2007","unstructured":"Parghi C, Mcknight GT, Pflugfelder SC (2007) Prominent corneal nerves in a patient with multiple myeloma. Cornea 26:220\u2013222. https:\/\/doi.org\/10.1097\/01.ICO.0000231492.89539.EB","journal-title":"Cornea"},{"key":"3467_CR73","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2147\/OPTH.S49283","volume":"8","author":"P Sharma","year":"2014","unstructured":"Sharma P, Madi HA, Bonshek R, Morgan SJ (2014) Cloudy corneas as an initial presentation of multiple myeloma. Clin Ophthalmol 8:813. https:\/\/doi.org\/10.2147\/OPTH.S49283","journal-title":"Clin Ophthalmol"},{"key":"3467_CR74","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1001\/ARCHOPHT.126.7.1005","volume":"126","author":"RZ Silkiss","year":"2008","unstructured":"Silkiss RZ, Pomerleau D, Sorenson A et al (2008) Corneal cupremia in multiple myeloma: a clinicopathologic correlation. Arch Ophthalmol 126:1005\u20131006. https:\/\/doi.org\/10.1001\/ARCHOPHT.126.7.1005","journal-title":"Arch Ophthalmol"},{"key":"3467_CR75","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0002-9394(00)00657-7","volume":"131","author":"AS Hawkins","year":"2001","unstructured":"Hawkins AS, Stein RM, Gaines BI, Deutsch TA (2001) Ocular deposition of copper associated with multiple myeloma. Am J Ophthalmol 131:257\u2013259. https:\/\/doi.org\/10.1016\/S0002-9394(00)00657-7","journal-title":"Am J Ophthalmol"},{"key":"3467_CR76","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/ARCHOPHT.1975.01010020824017","volume":"93","author":"RA Lewis","year":"1975","unstructured":"Lewis RA, Falls HF, Troyer DO (1975) Ocular manifestations of hypercupremia associated with multiple myeloma. Arch Ophthalmol 93:1050\u20131053. https:\/\/doi.org\/10.1001\/ARCHOPHT.1975.01010020824017","journal-title":"Arch Ophthalmol"},{"key":"3467_CR77","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5555\/URI:PII:0022214367900650","volume":"70","author":"SI Goodman","year":"1967","unstructured":"Goodman SI, Rodgerson DO, Kauffman J (1967) Hypercupremia in a patient with multiple myeloma. J Lab Clin Med 70:57\u201362. https:\/\/doi.org\/10.5555\/URI:PII:0022214367900650","journal-title":"J Lab Clin Med"},{"key":"3467_CR78","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1159\/000303353","volume":"135","author":"E Burki","year":"1958","unstructured":"Burki E (1958) Corneal changes in a case of multiple myeloma (plasmocytoma). Ophthalmologica 135:565\u2013572. https:\/\/doi.org\/10.1159\/000303353","journal-title":"Ophthalmologica"},{"key":"3467_CR79","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/ICO.0000000000001139","volume":"36","author":"LT Tainsh","year":"2017","unstructured":"Tainsh LT, Coady PA, Sinard JH et al (2017) Asymmetric deep stromal keratopathy in a patient with multiple myeloma. Cornea 36:372\u2013374. https:\/\/doi.org\/10.1097\/ICO.0000000000001139","journal-title":"Cornea"},{"key":"3467_CR80","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1056\/NEJMicm2203995","volume":"389","author":"T Ono","year":"2023","unstructured":"Ono T, Miyata K (2023) Corneal crystalline deposits in a patient with multiple myeloma. N Engl J Med 389:71\u201371. https:\/\/doi.org\/10.1056\/NEJMicm2203995","journal-title":"N Engl J Med"},{"key":"3467_CR81","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1038\/EYE.2017.132","volume":"31","author":"C Busch","year":"2017","unstructured":"Busch C, Koh S, Oie Y et al (2017) Increased corneal densitometry as a subclinical corneal change associated with multiple myeloma. Eye 31:1745. https:\/\/doi.org\/10.1038\/EYE.2017.132","journal-title":"Eye"},{"key":"3467_CR82","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1097\/01.ICO.0000240094.78095.F5","volume":"25","author":"RL Font","year":"2006","unstructured":"Font RL, Matoba AY, Prabhakaran VC (2006) IgG-kappa immunoglobulin deposits involving the predescemetic region in a patient with multiple myeloma. Cornea 25:1237\u20131239. https:\/\/doi.org\/10.1097\/01.ICO.0000240094.78095.F5","journal-title":"Cornea"},{"key":"3467_CR83","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/BJH.12047","volume":"159","author":"ST Nagendran","year":"2012","unstructured":"Nagendran ST, Pawlyn C, Brown M, Pelosini L (2012) Crystalline keratopathy associated with monoclonal gammopathy of undetermined significance. Br J Haematol 159:258. https:\/\/doi.org\/10.1111\/BJH.12047","journal-title":"Br J Haematol"},{"key":"3467_CR84","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.ophtha.2015.05.029","volume":"122","author":"T Milman","year":"2015","unstructured":"Milman T, Kao AA, Chu D et al (2015) Paraproteinemic keratopathy. Ophthalmology 122:1748\u20131756. https:\/\/doi.org\/10.1016\/j.ophtha.2015.05.029","journal-title":"Ophthalmology"},{"key":"3467_CR85","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0161-6420(88)33200-8","volume":"95","author":"LD Ormerod","year":"1988","unstructured":"Ormerod LD, Collin HB, Dohlman CH et al (1988) Paraproteinemic crystalline keratopathy. Ophthalmology 95:202\u2013212. https:\/\/doi.org\/10.1016\/S0161-6420(88)33200-8","journal-title":"Ophthalmology"},{"key":"3467_CR86","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/ICO.0B013E3181EE67FD","volume":"30","author":"DP Edward","year":"2011","unstructured":"Edward DP, Patil AJ, Sugar J, Parikh M (2011) Copper deposition in a variant of multiple myeloma: pathologic changes in the cornea and the lens capsule. Cornea 30:360\u2013363. https:\/\/doi.org\/10.1097\/ICO.0B013E3181EE67FD","journal-title":"Cornea"},{"key":"3467_CR87","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/EYE.2012.183","volume":"26","author":"JC Priluck","year":"2012","unstructured":"Priluck JC, Chalam KV, Grover S (2012) Spectral-domain optical coherence tomography of Roth spots in multiple myeloma. Eye 26:1588. https:\/\/doi.org\/10.1038\/EYE.2012.183","journal-title":"Eye"},{"key":"3467_CR88","doi-asserted-by":"publisher","first-page":"E277","DOI":"10.1503\/CMAJ.081968","volume":"181","author":"A Nautiyal","year":"2009","unstructured":"Nautiyal A, Amescua G, Jameson A et al (2009) Sudden loss of vision: purtscher retinopathy in multiple myeloma. CMAJ\u202f: Can Med Assoc J 181:E277. https:\/\/doi.org\/10.1503\/CMAJ.081968","journal-title":"CMAJ : Can Med Assoc J"},{"key":"3467_CR89","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1159\/000514695","volume":"12","author":"NFS Da Cruz","year":"2021","unstructured":"Da Cruz NFS, Filho JAPM, Ferraro DMN et al (2021) Hyperviscosity retinopathy and immunogammopathy maculopathy as new onset of multiple myeloma. Case Rep Ophthalmol 12:578\u2013584. https:\/\/doi.org\/10.1159\/000514695","journal-title":"Case Rep Ophthalmol"},{"key":"3467_CR90","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000529298","volume":"14","author":"CH Lin","year":"2023","unstructured":"Lin CH, Sun IT (2023) Bilateral simultaneous central retinal vein occlusion secondary to COVID-19: a case report. Case Rep Ophthalmol 14:56. https:\/\/doi.org\/10.1159\/000529298","journal-title":"Case Rep Ophthalmol"},{"key":"3467_CR91","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1016\/J.JCJO.2012.11.002","volume":"48","author":"M Ziaei","year":"2013","unstructured":"Ziaei M, Elgohary MA, Bremner FD (2013) Bilateral central retinal vein occlusion in multiple myeloma. Can J Ophthalmol 48:e24\u2013e25. https:\/\/doi.org\/10.1016\/J.JCJO.2012.11.002","journal-title":"Can J Ophthalmol"},{"key":"3467_CR92","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/CXO.12319","volume":"99","author":"CJ Borgman","year":"2016","unstructured":"Borgman CJ (2016) Concomitant multiple myeloma spectrum diagnosis in a central retinal vein occlusion: a case report and review. Clin Exp Optom 99:309\u2013312. https:\/\/doi.org\/10.1111\/CXO.12319","journal-title":"Clin Exp Optom"},{"key":"3467_CR93","doi-asserted-by":"publisher","first-page":"232","DOI":"10.5811\/CPCEM.2022.4.55710","volume":"6","author":"MA Tandlich","year":"2022","unstructured":"Tandlich MA, Williamson K (2022) Bilateral central retinal vein occlusion as a first presentation of multiple myeloma: a case report. Clin Pract Cases Emerg Med 6:232\u2013235. https:\/\/doi.org\/10.5811\/CPCEM.2022.4.55710","journal-title":"Clin Pract Cases Emerg Med"},{"key":"3467_CR94","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000078622","volume":"218","author":"FB Aggio","year":"2004","unstructured":"Aggio FB, Cariello AJ, Almeida MSS et al (2004) Bilateral central retinal vein occlusion associated with multiple myeloma. Ophthalmologica 218:283\u2013287. https:\/\/doi.org\/10.1159\/000078622","journal-title":"Ophthalmologica"},{"key":"3467_CR95","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1160\/TH08-01-0009","volume":"99","author":"F Gieseler","year":"2008","unstructured":"Gieseler F (2008) Pathophysiological considerations to thrombophilia in the treatment of multiple myeloma with thalidomide and derivates. Thromb Haemost 99:1001\u20131007. https:\/\/doi.org\/10.1160\/TH08-01-0009","journal-title":"Thromb Haemost"},{"key":"3467_CR96","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/J.CLML.2011.11.005","volume":"12","author":"FJ V\u00e1zquez","year":"2012","unstructured":"V\u00e1zquez FJ, Sobenko N, Schutz N et al (2012) Acute loss of vision as the initial symptom of multiple myeloma. Clin Lymphoma Myeloma Leuk 12:148\u2013150. https:\/\/doi.org\/10.1016\/J.CLML.2011.11.005","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"3467_CR97","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1159\/000525466","volume":"13","author":"A Baltmr","year":"2022","unstructured":"Baltmr A, Lotery A (2022) Multimodal imaging of vitelliform lesions in multiple myeloma: a case report. Case Rep Ophthalmol 13:523. https:\/\/doi.org\/10.1159\/000525466","journal-title":"Case Rep Ophthalmol"},{"key":"3467_CR98","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/ICB.0000000000000280","volume":"11","author":"A El Ameen","year":"2017","unstructured":"El Ameen A, Mrejen-Uretsky S, Abraham J et al (2017) Acquired vitelliform detachment in multiple myeloma. Retin Cases Brief Rep 11:27\u201329. https:\/\/doi.org\/10.1097\/ICB.0000000000000280","journal-title":"Retin Cases Brief Rep"},{"key":"3467_CR99","doi-asserted-by":"publisher","first-page":"bcr0520103049","DOI":"10.1136\/BCR.05.2010.3049","volume":"2010","author":"JM Khan","year":"2010","unstructured":"Khan JM, McBain V, Santiago C, Lois N (2010) Bilateral \u201cvitelliform-like\u201d macular lesions in a patient with multiple myeloma. BMJ Case Rep 2010:bcr0520103049. https:\/\/doi.org\/10.1136\/BCR.05.2010.3049","journal-title":"BMJ Case Rep"},{"key":"3467_CR100","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0161-6420(00)00118-4","volume":"107","author":"AC Ho","year":"2000","unstructured":"Ho AC, Benson WE, Wong J (2000) Unusual immunogammopathy maculopathy. Ophthalmology 107:1099\u20131103. https:\/\/doi.org\/10.1016\/S0161-6420(00)00118-4","journal-title":"Ophthalmology"},{"key":"3467_CR101","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/J.AJO.2013.11.020","volume":"157","author":"IM Rusu","year":"2014","unstructured":"Rusu IM, Mrejen S, Engelbert M et al (2014) Immunogammopathies and acquired vitelliform detachments: a report of four cases. Am J Ophthalmol 157:648\u201357.e1. https:\/\/doi.org\/10.1016\/J.AJO.2013.11.020","journal-title":"Am J Ophthalmol"},{"key":"3467_CR102","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2147\/TCRM.S79232","volume":"11","author":"B Dogan","year":"2015","unstructured":"Dogan B, Erol MK, Toslak D et al (2015) Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma. Ther Clin Risk Manag 11:683\u2013689. https:\/\/doi.org\/10.2147\/TCRM.S79232","journal-title":"Ther Clin Risk Manag"},{"key":"3467_CR103","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/ICB.0000000000000110","volume":"8","author":"LA Lam","year":"2014","unstructured":"Lam LA, Rodger DC (2014) Bilateral macular detachments, venous stasis retinopathy, and retinal hemorrhages as initial presentation of multiple myeloma: a case report. Retin Cases Brief Rep 8:240\u2013244. https:\/\/doi.org\/10.1097\/ICB.0000000000000110","journal-title":"Retin Cases Brief Rep"},{"key":"3467_CR104","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1080\/02713683.2022.2034886","volume":"47","author":"ME Dursun","year":"2022","unstructured":"Dursun ME, Erdem S, Karahan M et al (2022) Retinal microvascular changes in patients with multiple myeloma: a study based on optical coherence tomography angiography. Curr Eye Res 47:874\u2013881. https:\/\/doi.org\/10.1080\/02713683.2022.2034886","journal-title":"Curr Eye Res"},{"key":"3467_CR105","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/0002-9394(68)91786-8","volume":"66","author":"WV Delaney","year":"1968","unstructured":"Delaney WV, Liaricos SV (1968) Chorioretinal destruction in multiple myeloma. Am J Ophthalmol 66:52\u201355. https:\/\/doi.org\/10.1016\/0002-9394(68)91786-8","journal-title":"Am J Ophthalmol"},{"key":"3467_CR106","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1111\/AOS.12928","volume":"95","author":"C Brockmann","year":"2017","unstructured":"Brockmann C, Ingold Heppner B, Joussen AM (2017) Bilateral choroidal lesions as first sign of recurrence in multiple myeloma - histopathological findings and treatment response to bevacizumab. Acta Ophthalmol 95:e155\u2013e157. https:\/\/doi.org\/10.1111\/AOS.12928","journal-title":"Acta Ophthalmol"},{"key":"3467_CR107","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3341\/KJO.2021.0074","volume":"35","author":"JH Choi","year":"2021","unstructured":"Choi JH, Kim JH, Jeong JG (2021) Orbital and choroidal plasmacytoma in recurrent multiple myeloma: a case report. Korean J Ophthalmol 35:335. https:\/\/doi.org\/10.3341\/KJO.2021.0074","journal-title":"Korean J Ophthalmol"},{"key":"3467_CR108","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/CNCR.26447","volume":"118","author":"A Gozzetti","year":"2012","unstructured":"Gozzetti A, Cerase A, Lotti F et al (2012) Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: a retrospective survey of 50 patients. Cancer 118:1574\u20131584. https:\/\/doi.org\/10.1002\/CNCR.26447","journal-title":"Cancer"},{"key":"3467_CR109","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1182\/BLOOD-2004-03-0833","volume":"105","author":"T Rasmussen","year":"2005","unstructured":"Rasmussen T, Kuehl M, Lodahl M et al (2005) Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors. Blood 105:317\u2013323. https:\/\/doi.org\/10.1182\/BLOOD-2004-03-0833","journal-title":"Blood"},{"key":"3467_CR110","doi-asserted-by":"publisher","first-page":"ND01","DOI":"10.7860\/JCDR\/2016\/17418.7711","volume":"10","author":"BB Panda","year":"2016","unstructured":"Panda BB, Parija S, Mallick J, Pujahari S (2016) Oculomotor nerve palsy as a rare presentation and first sign of multiple myeloma. J Clin Diagn Res 10:ND01. https:\/\/doi.org\/10.7860\/JCDR\/2016\/17418.7711","journal-title":"J Clin Diagn Res"},{"key":"3467_CR111","doi-asserted-by":"publisher","DOI":"10.7759\/CUREUS.40998","volume":"15","author":"N Thalambedu","year":"2023","unstructured":"Thalambedu N, Damalcheruvu P, Ogunsesan Y et al (2023) Sixth nerve palsy from multiple myeloma in central nervous system: case series and review of current literature. Cureus 15:e40998. https:\/\/doi.org\/10.7759\/CUREUS.40998","journal-title":"Cureus"},{"key":"3467_CR112","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/AJH.10077","volume":"70","author":"M Nakagawa","year":"2002","unstructured":"Nakagawa M, Simizu Y, Suemura M, Sato B (2002) Unusual presentation of multiple myeloma with unilateral visual loss and numb chin syndrome in a young adult. Am J Hematol 70:55\u201359. https:\/\/doi.org\/10.1002\/AJH.10077","journal-title":"Am J Hematol"},{"key":"3467_CR113","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/BF00343609","volume":"219","author":"W Dahlmann","year":"1974","unstructured":"Dahlmann W, Grunwald F, Hauswaldt C (1974) Ig-A-myeloma with cerebrospinal manifestation. systematic localisation in pie mater and Virchow-Robin spaces, excessive increase of Ig-A in cerebrospinal fluid (author\u2019s transl). Arch Psychiatr Nervenkr 219:387\u2013400. https:\/\/doi.org\/10.1007\/BF00343609","journal-title":"Arch Psychiatr Nervenkr"},{"key":"3467_CR114","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/0002-9394(71)90580-0","volume":"71","author":"PP Gudas","year":"1971","unstructured":"Gudas PP (1971) Optic nerve myeloma. Am J Ophthalmol 71:1085\u20131089. https:\/\/doi.org\/10.1016\/0002-9394(71)90580-0","journal-title":"Am J Ophthalmol"},{"key":"3467_CR115","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/WNO.0B013E3181675457","volume":"28","author":"SN Yeung","year":"2008","unstructured":"Yeung SN, Paton KE, Dorovini-Zis K et al (2008) Histopathologic features of multiple myeloma involving the optic nerves. J Neuroophthalmol 28:12\u201316. https:\/\/doi.org\/10.1097\/WNO.0B013E3181675457","journal-title":"J Neuroophthalmol"},{"key":"3467_CR116","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3109\/01658107.2010.511395","volume":"34","author":"S Muoz","year":"2010","unstructured":"Muoz S, Acebes X, Arruga J et al (2010) Multiple myeloma presenting as bilateral posterior optic neuropathy. Neuro-Ophthalmol 34:351\u2013355. https:\/\/doi.org\/10.3109\/01658107.2010.511395","journal-title":"Neuro-Ophthalmol"},{"key":"3467_CR117","doi-asserted-by":"publisher","first-page":"446","DOI":"10.5301\/EJO.5000392","volume":"24","author":"AK Nugent","year":"2014","unstructured":"Nugent AK, Paulus YM, Chan A et al (2014) Multiple myeloma recurrence with optic nerve infiltration diagnosed by vitrectomy, immunohistochemistry, and in situ hybridization. Eur J Ophthalmol 24:446\u2013448. https:\/\/doi.org\/10.5301\/EJO.5000392","journal-title":"Eur J Ophthalmol"},{"key":"3467_CR118","doi-asserted-by":"publisher","DOI":"10.1136\/BCR-2020-239917","volume":"14","author":"T Vaid","year":"2021","unstructured":"Vaid T, Dhawan R, Aggarwal M, Tyagi S (2021) Isolated third cranial nerve palsy as the first presentation of multiple myeloma. BMJ Case Rep 14:e239917. https:\/\/doi.org\/10.1136\/BCR-2020-239917","journal-title":"BMJ Case Rep"},{"key":"3467_CR119","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1002\/AJH.26720","volume":"97","author":"A Tiu","year":"2022","unstructured":"Tiu A, Marks J, Aljuaid R et al (2022) Multiple myeloma with central nervous system relapse presenting as right pupil-sparing complete third nerve palsy. Am J Hematol 97:1666\u20131668. https:\/\/doi.org\/10.1002\/AJH.26720","journal-title":"Am J Hematol"},{"key":"3467_CR120","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000538120","volume":"15","author":"A Veisi","year":"2024","unstructured":"Veisi A, Daneshvar K, Hooshmandi S et al (2024) Superior oblique muscle extramedullary plasmacytoma in a patient with multiple myeloma and a review of literature. Case Rep Ophthalmol 15:265. https:\/\/doi.org\/10.1159\/000538120","journal-title":"Case Rep Ophthalmol"},{"key":"3467_CR121","doi-asserted-by":"publisher","first-page":"481","DOI":"10.4274\/TJO.04935","volume":"44","author":"SG G\u00fcng\u00f6r","year":"2014","unstructured":"G\u00fcng\u00f6r SG, Akkoyun \u0130, \u00c7oban-Karata\u015f M, Karaku\u015f S (2014) Multipl myelomlu bir olguda bilateral arka sklerit. Turk Oftalmoloiji Dergisi 44:481\u2013483. https:\/\/doi.org\/10.4274\/TJO.04935","journal-title":"Turk Oftalmoloiji Dergisi"},{"key":"3467_CR122","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/SJ.EYE.6701410","volume":"19","author":"JH Chan","year":"2005","unstructured":"Chan JH, Dua HS, Tranos PG et al (2005) Pseudohypopyon due to malignant infiltration of the anterior chamber in multiple myeloma. Eye 19:112\u2013113. https:\/\/doi.org\/10.1038\/SJ.EYE.6701410","journal-title":"Eye"},{"key":"3467_CR123","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/J.OPTM.2010.10.009","volume":"82","author":"KJ Chin","year":"2011","unstructured":"Chin KJ, Kempin S, Milman T, Finger PT (2011) Ocular manifestations of multiple myeloma: three cases and a review of the literature. Optometry 82:224\u2013230. https:\/\/doi.org\/10.1016\/J.OPTM.2010.10.009","journal-title":"Optometry"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03467-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03467-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03467-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:02:46Z","timestamp":1766167366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03467-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":123,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3467"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03467-9","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"assertion":[{"value":"24 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"89"}}